StemCell Therapy

Chen Q, Zeng X, Huang D, Qiu X. Identification of differentially expressed miRNAs in early-stage cervical cancer with lymph node metastasis across The Cancer Genome Atlas datasets. Cancer Manag Res. 2018;10:6489.

CAS Article Google Scholar

Parkin DM, Bray F. The burden of HPV-related cancers. Vaccine. 2006;24:S1125.

Article Google Scholar

Patel S, Chiplunkar S. Host immune responses to cervical cancer. Curr Opin Obstet Gynecol. 2009;21(1):549.

Article Google Scholar

Roden R, Wu T-C. How will HPV vaccines affect cervical cancer? Nat Rev Cancer. 2006;6(10):753.

CAS Article Google Scholar

Koshiol J, Lindsay L, Pimenta JM, Poole C, Jenkins D, Smith JS. Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol. 2008;168(2):12337.

Article Google Scholar

Small W Jr, Bacon MA, Bajaj A, Chuang LT, Fisher BJ, Harkenrider MM, et al. Cervical cancer: a global health crisis. Cancer. 2017;123(13):240412.

Article Google Scholar

Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 cells. Annu Rev Immunol. 2009;27:485517.

CAS Article Google Scholar

Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, et al. The orphan nuclear receptor RORt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 2006;126(6):112133.

CAS Article Google Scholar

Xie J, Wang J, Tang T, Chen J, Gao X, Yuan J, et al. The Th17/Treg functional imbalance during atherogenesis in ApoE/ mice. Cytokine. 2010;49(2):18593.

CAS Article Google Scholar

Zhu X, Ma D, Zhang J, Peng J, Qu X, Ji C, et al. Elevated interleukin-21 correlated to Th17 and Th1 cells in patients with immune thrombocytopenia. J Clin Immunol. 2010;30(2):2539.

CAS Article Google Scholar

Bettelli E, Oukka M, Kuchroo VK. T H-17 cells in the circle of immunity and autoimmunity. Nat Immunol. 2007;8(4):345.

CAS Article Google Scholar

Mougiakakos D, Choudhury A, Lladser A, Kiessling R, Johansson CC. Regulatory T cells in cancer. Adv Cancer Res. 2010;107:57117 Elsevier.

CAS Article Google Scholar

Wang R. Regulatory T cells and innate immune regulation in tumor immunity. Springer Semin Immunopathol. 2006;78:1723 Springer.

Article Google Scholar

Kieler M, Unseld M, Bianconi D, Prager G. Challenges and perspectives for immunotherapy in adenocarcinoma of the pancreas: the cancer immunity cycle. Pancreas. 2018;47(2):14257.

Article Google Scholar

Hwang JP, Ahmed S, Ariza-Heredia EJ, Duan Z, Zhao H, Schmeler KM, et al. Low rate of cervical cancer screening among women with hematologic malignancies after stem cell transplant. Biol Blood Marrow Transplant. 2018;24(5):10948.

Article Google Scholar

Lin W, Niu ZY, Zhang HL, Kong Y, Wang Z, Yang XS, Yuan F. Imbalance of Th1/Th2 and Th17/Treg during the development of uterine cervical cancer. Int J Clin Exp Pathol. 2019;12(9):360412.

CAS PubMed PubMed Central Google Scholar

Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):129.

CAS Article Google Scholar

Fridman WH. From Cancer immune surveillance to Cancer Immunoediting: birth of modern Immuno-oncology. J Immunol. 2018;201(3):8256.

CAS Article Google Scholar

Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med. 2004;10(9):9429.

CAS Article Google Scholar

Marigo I, Dolcetti L, Serafini P, Zanovello P, Bronte V. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunol Rev. 2008;222(1):16279.

CAS Article Google Scholar

Nakamura T, Shima T, Saeki A, Hidaka T, Nakashima A, Takikawa O, et al. Expression of indoleamine 2, 3-dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer. Cancer Sci. 2007;98(6):87481.

CAS Article Google Scholar

Adurthi S, Krishna S, Mukherjee G, Bafna UD, Devi U, Jayshree RS. Regulatory T cells in a spectrum of HPV-induced cervical lesions: cervicitis, cervical intraepithelial neoplasia and squamous cell carcinoma. Am J Reprod Immunol. 2008;60:5565.

CAS Article Google Scholar

Fattorossi A, Battaglia A, Ferrandina G, Buzzonetti A, Legge F, Salutari V, et al. Lymphocyte composition of tumor draining lymph nodes from cervical and endometrial cancer patients. Gynecol Oncol. 2004;92:10615.

CAS Article Google Scholar

Loddenkemper C, Hoffmann C, Stanke J, Nagorsen D, Baron U, Olek S, et al. Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer. Cancer Sci. 2009;100:11127.

CAS Article Google Scholar

Chen ZF, Ding JB, Pang NN, Du R, Meng W, Zhu YJ, et al. The Th17/Treg balance and the expression of related cytokines in Uygur cervical Cancer patients. Diagn Pathol. 2013;8:6171.

CAS PubMed PubMed Central Google Scholar

Zhang Y, Ma D, Zhang Y, Tian Y, Wang X, Qiao Y, et al. The imbalance of Th17/Treg in patients with uterine cervical cancer. Clin Chim Acta. 2011;412:894900.

CAS Article Google Scholar

Zhang B, Rong G, Wei H, Zhang M, Bi J, Ma L, et al. The prevalence of Th17 cells in patients with gastric cancer. Biochem Biophys Res Commun. 2008;374(3):5337.

CAS Article Google Scholar

Miller AM, Lundberg K, zenci V, Banham AH, Hellstrm M, Egevad L, et al. CD4+ CD25high T cells are enriched in the tumor and peripheral blood of prostate cancer patients. J Immunol. 2006;177(10):7398405.

CAS Article Google Scholar

Kryczek I, Wei S, Zou L, Altuwaijri S, Szeliga W, Kolls J, et al. Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J Immunol. 2007;178(11):67303.

CAS Article Google Scholar

Bais AG, Beckmann I, Ewing PC, Eijkemans MJ, Meijer CJ, Snijders PJ, et al. Cytokine release in HR-HPV. Mediat Inflamm. 2007;2007:24147.

Article Google Scholar

The rest is here:
The disease stage-associated imbalance of Th1/Th2 and Th17/Treg in uterine cervical cancer patients and their recovery with the reduction of tumor...

This entry was posted on June 17, 2020 at 11:44 am and is filed under Death by Stem Cells. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |